Applied Molecular Transport to Present at Jefferies Virtual London Healthcare Conference
2020年11月11日 - 10:00PM
Applied Molecular Transport (Nasdaq: AMTI) (AMT), a clinical-stage
biopharmaceutical company, today announced that Tahir Mahmood,
Ph.D., chief executive officer and co-founder of AMT, and Bittoo
Kanwar, M.D., chief medical officer of AMT, will participate in a
fireside chat during the Jefferies Virtual London Healthcare
Conference on Tuesday, November 17, 2020 at 12:00 p.m. ET / 5:00
p.m. GMT.
A live webcast will be accessible via the Events
page of the Applied Molecular Transport website at
https://ir.appliedmt.com/news-events/events. An archived replay
will be available for 30 days following the event.
About Applied Molecular Transport Inc.Applied
Molecular Transport Inc. is a clinical-stage biopharmaceutical
company leveraging its proprietary technology platform to design
and develop a pipeline of novel oral biologic product candidates to
treat autoimmune, inflammatory, metabolic, and other diseases.
AMT’s proprietary technology platform allows it to exploit existing
natural cellular trafficking pathways to facilitate the active
transport of diverse therapeutic modalities across the intestinal
epithelium (IE) barrier. Active transport is an efficient mechanism
that uses the cell’s own machinery to transport materials across
the IE barrier. AMT believes that its ability to exploit this
mechanism is a key differentiator of its approach. AMT is
developing additional oral biologic product candidates in
patient-friendly tablet and capsule forms that are designed to
either target local gastrointestinal tissue or enter systemic
circulation to precisely address the relevant biology of a
disease.
AMT’s headquarters, internal GMP manufacturing
and lab facilities are located in South San Francisco, CA. For
additional information on AMT, please visit www.appliedmt.com.
Investor Relations
Contact:Andrew ChangHead, Investor Relations &
Corporate Communicationsachang@appliedmt.com
Media Contacts:Alexandra SantosWheelhouse Life
Science Advisorsasantos@wheelhouselsa.com
Aljanae ReynoldsWheelhouse Life Science
Advisorsareynolds@wheelhouselsa.com
Applied Molecular Transp... (NASDAQ:AMTI)
過去 株価チャート
から 9 2024 まで 10 2024
Applied Molecular Transp... (NASDAQ:AMTI)
過去 株価チャート
から 10 2023 まで 10 2024